R 031944Z JUN 05 – June 3, 2005FROM: American Embassy BrasiliaTO: Secretary of State, Washington, D.C.SUBJECT: AMBASSADOR MEETS WITH U.S. PHARMACEUTICAL FIRMS THREATENED WITH LICENSING 1. (SBU) Summary. On May 24 and 25, U.S. pharmaceutical companies Gilead Sciences, Abbott Laboratories,… Continue Reading →
This is a letter, dated July 22, 2004, by six consumer groups, asking Robert Zoellick and other members of the Bush Administration, to change US trade policy, so that research and development, rather than intellectual property rights, were the focus.… Continue Reading →
Sep 16, 2010 A New Trade Framework for Global Healthcare R&D[1] Access to Medicines and the Financing of Innovations in Health Care Workshop Hosted by the Program on Science, Technology, and Global Development, The Earth Institute at Columbia University, and… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/cptech08302003.html CPTech Statement on WTO Deal on Exports of Medicines August 30, 2003 “Today’s decision on the implementation of paragraph 6 of the Doha Declaration on TRIPS and Public Health puts the WTO into unchartered waters. The WTO… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/zoellick02102003.doc RECEIVED 24 FEB 2003 Executive Office of the President The United States Trade Representative Washington, DC 20508 February 10, 2003 Mr. James Love Co-Chair TACD IP-workinggroup TACD Secretariat 24 Highbury Crescent UK-London N5 1RXDear Mr. Love, Thank… Continue Reading →
Original page: http://www.cptech.org/ip/wto/p6/lamy12172002.doc Pascal Lamy Rue de la Loi,… Continue Reading →
Original: Page 1 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p1.jpg Page 2 – http://www.cptech.org/ip/health/eu/lamy2tacd20mar2002-p2.jpg Note by James Love on April 1, 2002 via IP-Health email list regarding the letter below (archived link of the note here): This these are scans of Pascal Lamy’s March 20… Continue Reading →
Implementing TRIPS safeguards with particular attention to administrative models for compulsory licensing of patents WHO meeting in Harare, ZimbabweAugust 21, 2001(with additional references to November Doha declaration) James LoveConsumer Project on Technology I. Introduction. TRIPS obligations raise broad public health… Continue Reading →
Ralph Nader P.O. Box 19312 Washington, DC 20036 July 23, 2001 Dr. Gro Harlem Brundtland Director-General World Health Organization Avenue Appia 20 1211 Geneva 27 Switzerland Dear Dr. Brundtland: It has been encouraging in recent years to see the WHO… Continue Reading →
July 6, 2001 Mr. Ralph Nader P.O. Box 19312 Washington, D.C. 20036 Dear Mr. Nader: I am writing in response to the letter from you and your colleagues requesting that the Department of Health and Human Services (HHS) grant the… Continue Reading →